Clinical Trials Protocol Authoring using LLMs

This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of...

Full description

Saved in:
Bibliographic Details
Published in:arXiv.org 2024-08
Main Authors: Maleki, Morteza, Ghahari, SeyedAli
Format: Article
Language:English
Subjects:
Authoring
Generative artificial intelligence
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title arXiv.org
container_volume
creator Maleki, Morteza
Ghahari, SeyedAli
description This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols. The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation. Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements. Challenges encountered during model selection and prompt engineering were systematically addressed, leading to refined methodologies that capitalized on the advanced text generation capabilities of GPT-4. This project not only showcases the practical applications and benefits of generative AI in clinical trial design but also sets a foundation for future innovations in the field.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_3034837183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3034837183</sourcerecordid><originalsourceid>FETCH-proquest_journals_30348371833</originalsourceid><addsrcrecordid>eNpjYuA0MjY21LUwMTLiYOAtLs4yMDAwMjM3MjU15mTQdc7JzMtMTsxRCCnKTMwpVggoyi_JT87PUXAsLcnIL8rMS1coLQaRPj6-xTwMrGlARam8UJqbQdnNNcTZQ7egKL-wNLW4JD4rv7QoDygVb2xgbGJhbG5oYWxMnCoAok8xsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3034837183</pqid></control><display><type>article</type><title>Clinical Trials Protocol Authoring using LLMs</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Maleki, Morteza ; Ghahari, SeyedAli</creator><creatorcontrib>Maleki, Morteza ; Ghahari, SeyedAli</creatorcontrib><description>This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols. The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation. Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements. Challenges encountered during model selection and prompt engineering were systematically addressed, leading to refined methodologies that capitalized on the advanced text generation capabilities of GPT-4. This project not only showcases the practical applications and benefits of generative AI in clinical trial design but also sets a foundation for future innovations in the field.</description><identifier>EISSN: 2331-8422</identifier><language>eng</language><publisher>Ithaca: Cornell University Library, arXiv.org</publisher><subject>Authoring ; Generative artificial intelligence</subject><ispartof>arXiv.org, 2024-08</ispartof><rights>2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/3034837183?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>777,781,25734,36993,44571</link.rule.ids></links><search><creatorcontrib>Maleki, Morteza</creatorcontrib><creatorcontrib>Ghahari, SeyedAli</creatorcontrib><title>Clinical Trials Protocol Authoring using LLMs</title><title>arXiv.org</title><description>This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols. The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation. Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements. Challenges encountered during model selection and prompt engineering were systematically addressed, leading to refined methodologies that capitalized on the advanced text generation capabilities of GPT-4. This project not only showcases the practical applications and benefits of generative AI in clinical trial design but also sets a foundation for future innovations in the field.</description><subject>Authoring</subject><subject>Generative artificial intelligence</subject><issn>2331-8422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpjYuA0MjY21LUwMTLiYOAtLs4yMDAwMjM3MjU15mTQdc7JzMtMTsxRCCnKTMwpVggoyi_JT87PUXAsLcnIL8rMS1coLQaRPj6-xTwMrGlARam8UJqbQdnNNcTZQ7egKL-wNLW4JD4rv7QoDygVb2xgbGJhbG5oYWxMnCoAok8xsQ</recordid><startdate>20240804</startdate><enddate>20240804</enddate><creator>Maleki, Morteza</creator><creator>Ghahari, SeyedAli</creator><general>Cornell University Library, arXiv.org</general><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope></search><sort><creationdate>20240804</creationdate><title>Clinical Trials Protocol Authoring using LLMs</title><author>Maleki, Morteza ; Ghahari, SeyedAli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_30348371833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Authoring</topic><topic>Generative artificial intelligence</topic><toplevel>online_resources</toplevel><creatorcontrib>Maleki, Morteza</creatorcontrib><creatorcontrib>Ghahari, SeyedAli</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>Engineering Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maleki, Morteza</au><au>Ghahari, SeyedAli</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>Clinical Trials Protocol Authoring using LLMs</atitle><jtitle>arXiv.org</jtitle><date>2024-08-04</date><risdate>2024</risdate><eissn>2331-8422</eissn><abstract>This report embarks on a mission to revolutionize clinical trial protocol development through the integration of advanced AI technologies. With a focus on leveraging the capabilities of generative AI, specifically GPT-4, this initiative aimed to streamline and enhance the efficiency and accuracy of clinical trial protocols. The methodology encompassed a detailed analysis and preparation of comprehensive drug and study level metadata, followed by the deployment of GPT-4 for automated protocol section generation. Results demonstrated a significant improvement in protocol authoring, highlighted by increases in efficiency, accuracy, and the customization of protocols to specific trial requirements. Challenges encountered during model selection and prompt engineering were systematically addressed, leading to refined methodologies that capitalized on the advanced text generation capabilities of GPT-4. This project not only showcases the practical applications and benefits of generative AI in clinical trial design but also sets a foundation for future innovations in the field.</abstract><cop>Ithaca</cop><pub>Cornell University Library, arXiv.org</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2331-8422
ispartof arXiv.org, 2024-08
issn 2331-8422
language eng
recordid cdi_proquest_journals_3034837183
source Publicly Available Content Database (Proquest) (PQ_SDU_P3)
subjects Authoring
Generative artificial intelligence
title Clinical Trials Protocol Authoring using LLMs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T14%3A23%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=Clinical%20Trials%20Protocol%20Authoring%20using%20LLMs&rft.jtitle=arXiv.org&rft.au=Maleki,%20Morteza&rft.date=2024-08-04&rft.eissn=2331-8422&rft_id=info:doi/&rft_dat=%3Cproquest%3E3034837183%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_30348371833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3034837183&rft_id=info:pmid/&rfr_iscdi=true